Buradasınız

Anasayfa » Content

Genç Bir Hastada; Myoma Uteri, Kolon Adenokarsinomu ve Üreteral Duplikasyon Birlikteliği

Coexistent Uterine Myoma, Colon Adenocarcinoma Ureteral Duplication in A Young Female Patient

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2004

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Uterine leiomyomas are the most common solid pelvic tumor and a common indication for hysterectomy in women. Ureteral duplication may be genetically determined by an autosomal dominant trait with incomplete penetrance. Colorectal carcinomas are the second most common internal malignancy. When the literature is reviewed we could not find any report showing a relationship among these pathologic conditions. To our knowledge so far, this is the first report describing the incidental finding of leiomyoma uteri, double ureter and colon adenocarcinoma in a young female patient, therefore this case is presented.
Bookmark/Search this post with
Abstract (Original Language): 
Öz geçmişinde genital sistem kanseri hikayesi olan kadınlarda kolorektal kanser görülme riskinin artmış olmasına rağmen, uterin myom varlığı ile kolon kanserleri arasında herhangi bir ilişki bildirilmemiştir. Öte yandan bazı gastrointestinal sistem lezyonları ile üreteral kollektör sistem duplikasyonunun birlikte görülebilmesine rağmen, uterin myoma, kolon kanseri ve üreteral dublikasyonun birlikteliği rapor edilmemiştir. Biz, bu üç farklı patolojik bulgunun genç bir hastadaki rastlantısal birlikteliğini, tanı ve tedavisindeki yaklaşım şeklini tartıştık.
FULL TEXT (PDF): 
PDF icon arastirmax-genc-bir-hastada-myoma-uteri-kolon-adenokarsinomu-ureteral-duplikasyon-birlikteligi.pdf
  • 3
181-183
  • Turkish

REFERENCES

References: 

1. Wallach EE: Myomectomy. In: Thompson JD, Rock JA, eds. Te Linde's Operative Gynecology. 7th ed. Philadelphia, Pa: Lippincott, 1992; 647-662.
2. Bond JH: Colorectal Cancer Update. Prevention, Screening, Treatment and Surveillance for High-Risk Groups. Med Clin N Am 2000; 84:1163-1182.
3. Henry TL, Murray JC, Trudy GS, Jane FL. Hereditary Factors in Gynecologic Cancer. Tie Oncologist 1998;3:319-338.
4. Atwell JD, Cook PL, Howell CJ, et al: Familial incidence of bifid and douple ureters. Arch Dis Child 1974; 49:390.
5. Cromie WJ, Engelstein MS, Duckett JW Jr: Nodular renal blastema, renal dysplasia and duplicated collecting systems. J Urol 1980; 123:100.
6. Koshiyama M, Morita Y, Fujii H, Kobashi Y, Yoshida M. Gynecologic malignancies accompanied by benign hormone-dependent diseases. Menopause 2001;8:149-50.
7. Shebani KO, Souba WW, Finkelstein DM et al. Prognosis and Survival in Patients With Gastrointestinal Tract Carcinoid Tumors. Annals of Surgery 1999;229:815-823.

Thank you for copying data from http://www.arastirmax.com